In the TCGA combined study, and when analyzing MEK5, sarcoma was identified as the tumor type with the third-highest molecular alteration frequency, with gene alteration in 2.5% of the cases (Supplementary Fig. 3a). The gene discussed is MAP2K5; the disease is sarcoma.